
A comprehensive review published in JAMA in May 2024 by National Institutes of Health researchers marks the 30-year milestone of the Women's Health Initiative (WHI), the largest women's health study in United States history. This analysis synthesizes findings from over 68,000 postmenopausal women followed for up to 20 years, offering crucial insights that continue to guide evidence-based care for millions of women worldwide.
The WHI fundamentally transformed understanding of hormone replacement therapy, challenging decades of conventional medical wisdom. The study found that estrogen or combination estrogen-progestin therapy had varying outcomes with chronic conditions, and evidence does not support using these therapies to reduce risks for heart disease, stroke, cancer, and dementia. Critically, researchers emphasized that the study was not designed to assess hormone therapy's effectiveness for treating menopausal symptoms, benefits that had been established before the WHI began. This distinction proved vital for clinical practice, as the findings led to more nuanced approaches recognizing that women younger than 60 with low-to-average cardiovascular and breast cancer risk may experience greater benefits than risks when using hormone therapy for moderate-to-severe menopausal symptoms like bothersome hot flashes or night sweats.
The study's bone health findings equally surprised the medical community. Combined calcium and vitamin D supplementation was not associated with reduced hip fracture risks among postmenopausal women at average osteoporosis risk, despite widespread belief in supplementation benefits. However, researchers noted that supplements can help fill nutrient gaps for women not meeting daily recommended intake levels, shifting practice from universal supplementation to individualized approaches emphasizing adequate dietary intake.
Dietary intervention results revealed complex relationships between nutrition and health outcomes. While a low-fat dietary pattern with increased fruits, vegetables, and grains did not reduce breast or colorectal cancer risk initially, subsequent long-term analyses found this eating pattern associated with reduced breast cancer mortality, demonstrating the importance of extended follow-up in clinical research.
The NIH review emphasizes that findings can vary based on multiple factors, including age and underlying cardiovascular disease risks, reinforcing that women ages 50 and older should work with clinicians to make individualized, shared medical decisions. This personalized approach represents the WHI's lasting legacy, transforming women's health care from universal recommendations to evidence-based, patient-centered decision-making that considers each woman's unique risk profile, preferences, and circumstances.